AstraZeneca ' s Imfinzi Improves Survival in Late-stage Lung Cancer Trial AstraZeneca ' s Imfinzi Improves Survival in Late-stage Lung Cancer Trial

AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the...Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news